Reimagining GCT Production - 2022 World Medical Innovation Forum

Reimagining GCT Production

Reimagining GCT Production

Wednesday, May 4, 2022

9:55 AM – 10:20 AM America Ballroom View Here

What is the new generation of approaches to gene therapy manufacturing and delivery? What are the lessons learned from Covid and how can it be applied to custom disease response and the ability to custom design biologic organisms?

Derik de Bruin, PhD
  • Managing Director, Global Research, BofA Securities
Jason Kelly, PhD
  • Co-Founder & CEO, Ginkgo Bioworks